Skip NavigationSkip to Content

Overexpression of Phosphoinositide-Specific Phospholipase C-Gamma in Nih 3t3 Cells Promotes Transformation and Tumorigenicity

  1. Author:
    Smith, M. R.
    Court, D. W.
    Kim, H. K.
    Park, J. B.
    Rhee, S. G.
    Rhim, J. S.
    Kung, H. F.
    1. Year: 1998
  1. Journal: Carcinogenesis
    1. 19
    2. 1
    3. Pages: 177-185
  2. Type of Article: Article
  1. Abstract:

    Phosphoinositide-specific phospholipase C gamma (PLC gamma) is a key regulatory enzyme that binds to the phosphoryl-tyrosine residues in the cytoplasmic domain of certain activated receptors and catalyses the hydrolysis of phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P-2] forming IP3 and diacylglycerol (DAG) in response to several mitogenic factors, Previously, me determined that microinjected PLC gamma induces DNA synthesis in G(0)-arrested NIH 3T3 cells, suggesting the possibility that PLC gamma mag have an oncogenic potential, In this report, we demonstrate that overexpression of PLC gamma in NIH 3T3 cells results in altered growth properties and cellular transformation, The PLC gamma/3T3 transfectants do not require serum growth factors to proliferate, display anchorage-independent growth in soft agar and induce tumors when transplanted into nude mice. These findings suggest that overexpression of PLC gamma facilitates the transformation of NIH 3T3 cells. Furthermore, PLC gamma expression and activity have been shown to be elevated in many human tumors, Thus, PLC gamma signaling may contribute to the promotion and/or progression of human cancers. [References: 55]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel